The ADA is over and the Endo Society has finished their annual meeting and now we have to get back to the real world of managing patients, battling insurance companies and hoping that we finally get our payments from Medicare. There was a lot of great science at both conferences but most of it was proof of things we already knew. Studies that show adding bolus to basal insulin improves A1c’s or that exercise prevents young boys from developing diabetes seem to be almost redundant when you think about it. These and many others that were presented remind us of how much we already know and how much more we can do to help our patients to better outcomes. There was some good news on a couple of new drug classes and how they might be of great benefit to our patients.
During a run through the poster presentations at ADA, I saw a lot of weight loss studies for diabetes patients. Much of it focused on weight loss and BMI. But not all weight loss is created equal. Sheri Colberg, Ph.D., has researched the muscle wasting associated with many weight loss programs and how sarcopenia can vastly decrease our quality of life and speed up the aging process. Read her new article Sarcopenic Obesity: Just One of the Many Potential Perils of Weight Loss without Exercise.
TCOYD 2010 Mini-Series, Wednesday, July 28, 2010, San Diego, CA: Type 1 Night Closing the Loop
“Type 1 Night Closing the Loop: Bridging the gap until there is a cure” hosted by Steven V. Edelman, MD. Guest Speakers: Howard Zisser, MD, Sansum Diabetes Research Institute, Santa Barbara. Who Should Attend: All people with Type 1 diabetes and their family members and loved ones. Goal: Gain knowledge about closing the loop and experience the camaraderie of being with fellow Type 1’s and their families. For more 2010 upcoming conference details, please go to TCOYD.org.
dLife.com: July 4, 7PM ET on CNBC
Topics: Actress, comedienne, and “The View” co-host Sherri Shepherd talks candidly about her diabetes life. Plus, Jim Turner examines the wild world of competitive eating. Special Guest: Sherri Shepherd. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.
Please answer this week’s Poll question:
Will you recommend MannKind’s inhaled insulin Afrezza®, if approved? (See this week’s Item #11.)
Check out this week’s “Test Your Diabetes Knowledge” question!
Dave Joffe, Editor-in-chief